Viral infection of central nervous system
MONDO:0024318Also known as: viral infection of central nervous system, central nervous system viral infection, viral disease of central nervous system
61 clinical trials for this condition and its sub-types, 3 tagged with Viral infection of central nervous system itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Viral infection of central nervous system
-
Poliomyelitis 28 trials · 39 incl. sub-types
3 sub-types
- Postpoliomyelitis syndrome 11 trials
- Acute nonparalytic poliomyelitis 0 trials
- Paralytic poliomyelitis 0 trials Sub-types →
-
Viral encephalitis 3 trials · 17 incl. sub-types
12 sub-types
- Tick-borne encephalitis 6 trials
- Mosquito-borne viral encephalitis 0 trials · 5 incl. sub-types Sub-types →
- Herpes simplex encephalitis 2 trials
- Acute hemorrhagic encephalitis 0 trials · 1 incl. sub-types Sub-types →
- Acute necrotizing encephalitis 1 trial
- Eastern equine encephalitis 1 trial
- Colorado tick fever 0 trials
- HHV-6 encephalitis 0 trials
- Powassan encephalitis 0 trials
- Borna virus encephalitis 0 trials
- Encephalitis lethargica 0 trials
- Subacute sclerosing panencephalitis 0 trials
-
Venezuelan equine encephalitis 1 trial
-
Lymphocytic choriomeningitis 1 trial
-
Geniculate herpes zoster 0 trials
-
Meningitis caused by poliovirus 0 trials
Most studied deeper sub-types
-
One shot, six protections: can a new vaccine match current standards?
Vaccine Not yet recruitingThis phase 3 trial tests a new combination vaccine called BK1803 in healthy infants aged 2 to 7 months. The vaccine aims to protect against six diseases: whooping cough, diphtheria, tetanus, polio, hepatitis B, and Haemophilus influenzae type b. Researchers compare BK1803 to a st…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Vaccine
Last updated Aug 30, 2026 00:00 UTC
-
Next-Generation polio vaccine enters human testing
Vaccine Not yet recruitingThis trial tests a new recombinant polio vaccine (rPV) against the current standard IPOL vaccine in healthy adults aged 18 to 60. The goal is to see if the new vaccine is safe and triggers a strong immune response. It is a small, early-stage study to gather initial data.
Phase 1 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Vaccine
Last updated Jul 12, 2026 00:00 UTC
-
New antibody shot could shield against Tick-Borne brain virus
Prevention Not yet recruitingThis early-stage study tests a lab-made antibody called TBE025 in 18 healthy adults aged 18 to 55. The goal is to see if it is safe and how the body processes it when given through a vein. Participants receive one dose and are closely monitored for side effects. This research hel…
Phase 1 • Sponsor: Giuseppe Pantaleo • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New study tracks brain health in kids after stem cell transplants
Knowledge-focused Not yet recruitingThis observational study will follow 100 children in Denmark who receive a stem cell transplant for blood cancer or other serious blood disorders. Researchers will test their thinking skills, physical abilities, and daily activity before the transplant and for one year after. The…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Do childhood vaccines last? 5-year follow-up study launched in china
Knowledge-focused Not yet recruitingThis study follows 600 Chinese children who received standard vaccines against polio, measles, mumps, rubella, and hepatitis A. Researchers will test their blood to see if protective antibodies remain 5 years after vaccination. The goal is to understand how long vaccine protectio…
Sponsor: China National Biotec Group Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
AI vs. experts: can a computer judge speech as well as a human?
Knowledge-focused Not yet recruitingThis study will compare how well an AI program (Blings) measures speech clarity in 40 adults with speech disorders from stroke or other neurological conditions. Two speech therapists will also rate the same speech samples. The goal is to see if the AI can reliably replace or assi…
Sponsor: Pusan National University Yangsan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Silent threat: study to uncover hidden spread of brain infection in cambodian kids
Knowledge-focused Not yet recruitingThis study will follow 4,000 children in Cambodia to understand how common Japanese Encephalitis (JE) is and how often it spreads without symptoms. Researchers will compare healthy children with those hospitalized for fever and brain-related symptoms. The goal is to measure the t…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:48 UTC
-
New study aims to uncover why some kids face brain fog after bone marrow transplant
Knowledge-focused Not yet recruitingThis study will follow 175 children and young adults who had a bone marrow transplant before age 18. Researchers will test their thinking, memory, and attention skills, and check for links to physical health issues like metabolism and fitness. The goal is to find early warning si…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:59 UTC